| AURKA (AurA) | Aur | Other | 2wtv | A | A | 4-{[9-chloro-7-(2,6-difluorophenyl)-5h-pyrimido[5,4-d][2]benzazepin-2-yl]amino}benzoic acid | Human | 2056 | 1.00 | |
| AURKA (AurA) | Aur | Other | 2x81 | A | | 4-{[9-chloro-7-(2,6-difluorophenyl)-5h-pyrimido[5,4-d][2]benzazepin-2-yl]amino}benzoic acid | Human | 1966 | 1.00 | |
| AURKA (AurA) | Aur | Other | 2wtv | A | B | 4-{[9-chloro-7-(2,6-difluorophenyl)-5h-pyrimido[5,4-d][2]benzazepin-2-yl]amino}benzoic acid | Human | 1997 | 1.00 | |
| EPHA2 (EphA2) | Eph | TK | 5ia0 | B | B | alisertib | Human | 7179 | 0.70 | |
| EPHA2 (EphA2) | Eph | TK | 5ia0 | C | A | alisertib | Human | 7186 | 0.70 | |
| AURKA (AurA) | Aur | Other | 2wtv | B | A | 4-{[9-chloro-7-(2,6-difluorophenyl)-5h-pyrimido[5,4-d][2]benzazepin-2-yl]amino}benzoic acid | Human | 2037 | 1.00 | |
| EPHA2 (EphA2) | Eph | TK | 5ia0 | A | B | alisertib | Human | 7171 | 0.70 | |
| EPHA2 (EphA2) | Eph | TK | 5ia0 | B | A | alisertib | Human | 7174 | 0.70 | |
| EPHA2 (EphA2) | Eph | TK | 5ia0 | A | A | alisertib | Human | 7169 | 0.70 | |
| AURKA (AurA) | Aur | Other | 2wtw | A | | 4-{[9-chloro-7-(2,6-difluorophenyl)-5h-pyrimido[5,4-d][2]benzazepin-2-yl]amino}benzoic acid | Human | 1956 | 1.00 | |
| MAPK1 (Erk2) | MAPK | CMGC | 4fv4 | A | B | 9-(dimethylamino)-2-[(3-hydroxyphenyl)amino]-5,6-dihydrothieno[3,4-h]quinazoline-7-carbonitrile | Human | 2558 | 0.40 | |
| AURKA (AurA) | Aur | Other | 3h10 | D | | 9-chloro-7-(2,6-difluorophenyl)-n-{4-[(4-methylpiperazin-1-yl)carbonyl]phenyl}-5h-pyrimido[5,4-d][2]benzazepin-2-amine | Human | 2059 | 0.79 | |
| EPHA2 (EphA2) | Eph | TK | 5ia0 | C | B | alisertib | Human | 7175 | 0.70 | |
| AURKA (AurA) | Aur | Other | 3uo5 | A | | 4-{[4-(phenylamino)pyrimidin-2-yl]amino}benzoic acid | Human | 2045 | 0.40 | |
| AURKA (AurA) | Aur | Other | 3uok | B | | 4-({4-[(2-chlorophenyl)amino]-5-fluoropyrimidin-2-yl}amino)benzoic acid | Human | 2047 | 0.50 | |
| AURKA (AurA) | Aur | Other | 2wtv | C | A | 4-{[9-chloro-7-(2,6-difluorophenyl)-5h-pyrimido[5,4-d][2]benzazepin-2-yl]amino}benzoic acid | Human | 2017 | 1.00 | |
| AURKA (AurA) | Aur | Other | 3h10 | A | | 9-chloro-7-(2,6-difluorophenyl)-n-{4-[(4-methylpiperazin-1-yl)carbonyl]phenyl}-5h-pyrimido[5,4-d][2]benzazepin-2-amine | Human | 2009 | 0.79 | |
| AURKA (AurA) | Aur | Other | 2wtv | D | A | 4-{[9-chloro-7-(2,6-difluorophenyl)-5h-pyrimido[5,4-d][2]benzazepin-2-yl]amino}benzoic acid | Human | 2078 | 1.00 | |
| MAPK1 (Erk2) | MAPK | CMGC | 4fv4 | A | A | 9-(dimethylamino)-2-[(3-hydroxyphenyl)amino]-5,6-dihydrothieno[3,4-h]quinazoline-7-carbonitrile | Human | 2623 | 0.40 | |
| CDK2 | CDK | CMGC | 3unj | A | | 4-{[4-(phenylamino)pyrimidin-2-yl]amino}benzoic acid | Human | 4498 | 0.40 | |
| AURKA (AurA) | Aur | Other | 2wtv | D | B | 4-{[9-chloro-7-(2,6-difluorophenyl)-5h-pyrimido[5,4-d][2]benzazepin-2-yl]amino}benzoic acid | Human | 2076 | 1.00 | |
| AURKA (AurA) | Aur | Other | 3h10 | B | | 9-chloro-7-(2,6-difluorophenyl)-n-{4-[(4-methylpiperazin-1-yl)carbonyl]phenyl}-5h-pyrimido[5,4-d][2]benzazepin-2-amine | Human | 1988 | 0.79 | |
| AURKA (AurA) | Aur | Other | 3unz | A | | 4-({4-[(2-fluorophenyl)amino]pyrimidin-2-yl}amino)benzoic acid | Human | 1972 | 0.42 | |
| AURKA (AurA) | Aur | Other | 3unz | B | | 4-({4-[(2-fluorophenyl)amino]pyrimidin-2-yl}amino)benzoic acid | Human | 2049 | 0.42 | |
| AURKA (AurA) | Aur | Other | 2wtv | B | B | 4-{[9-chloro-7-(2,6-difluorophenyl)-5h-pyrimido[5,4-d][2]benzazepin-2-yl]amino}benzoic acid | Human | 2057 | 1.00 | |
| AURKA (AurA) | Aur | Other | 3uok | A | | 4-({4-[(2-chlorophenyl)amino]-5-fluoropyrimidin-2-yl}amino)benzoic acid | Human | 2054 | 0.50 | |
| AURKA (AurA) | Aur | Other | 2wtv | C | B | 4-{[9-chloro-7-(2,6-difluorophenyl)-5h-pyrimido[5,4-d][2]benzazepin-2-yl]amino}benzoic acid | Human | 2016 | 1.00 | |
| EPHA2 (EphA2) | Eph | TK | 5ia1 | A | | 4-{[9-chloro-7-(2,6-difluorophenyl)-5h-pyrimido[5,4-d][2]benzazepin-2-yl]amino}benzoic acid | Human | 7191 | 1.00 | |
Match: